Abstract:Objective To clone the recombinant plasmid silencing vascular endothelial growth factor-C (VEGF-C) gene by small interfering RNA (siRNA) and observe its role in the expression of COX-2 , Bcl-2 and proliferation in human breast cancer cells MDA-MB-435. Methods Breast cancer cells MDA-MBA-435 were transfected stably with the recombinant siRNA plasmid and negative control by positive liposomal methods. We examined the gene expression of VEGF-C, COX-2 by RT-PCR and protein expression of VEGF-C, COX-2 and Bcl-2 by Western blot to explore the effect of VEGF-C down-regulation. The influences on cell activity and apoptosis were studied by MTT and flow cytometry. Results The down-regulation of VEGF-C inhibited the expression of some other genes such as COX-2 and bcl-2. The apoptosis rate was 60% after transfection 72 hours, and grew much slower than control groups. Conclusions The results obtained explain the function of VEGF-C and the cross-talk of downstream tyrosine kinase. Silencing of VEGF-C expression using siRNA vectors inhibits cell activity and induces apoptosis in human breast cancer cells MDA-MBA-435, which is a potential approach for tumor gene therapy.

Vascular endothelial cell growth factor-C small RNA interfering vector down-regulate COX-2, Bel-2 and induce apoptosis in human breast cancer cells